Related Experiment Video

Updated: May 20, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Targeting autophagic pathways for cancer drug discovery

Bo Liu1, Jin-Ku Bao, Jin-Ming Yang

  • 1School of Life Sciences, Sichuan University, Chengdu, People's Republic of China.

Chinese Journal of Cancer
|July 28, 2012
PubMed

Insights

Autophagy, a cellular process, is vital in cancer development and progression. Targeting autophagy pathways offers a promising strategy for developing novel cancer therapies.

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Biology

Background:

  • Autophagy is an evolutionarily conserved lysosomal degradation process.
  • Autophagy significantly influences cell survival and death signaling pathways in cancer.
  • Key mediators like autophagy-related genes (ATGs), PI3K, mTOR, p53, and Beclin-1 are crucial in cancer-related autophagy.

Purpose of the Study:

  • To review the current understanding of targeting autophagic pathways for cancer therapy.
  • To highlight the role of autophagy in cancer initiation and progression.
  • To explore the potential of autophagy modulation as a therapeutic strategy.

Main Methods:

  • Literature review of studies on autophagy and cancer.
  • Analysis of the roles of key autophagic mediators in cancer.
  • Discussion of existing and potential autophagy-modulating agents for cancer treatment.

Main Results:

  • Autophagy plays a dual role in cancer, influencing both initiation and progression.
  • Specific autophagy mediators are critical in regulating cancer cell fate.
  • Clinical agents targeting autophagy, such as rapamycin and chloroquine, are already in use.

Conclusions:

  • Targeting autophagic pathways presents a novel therapeutic opportunity in oncology.
  • A deeper understanding of autophagy regulation can enhance its exploitation for cancer treatment.
  • Further research into autophagy modulation holds promise for developing innovative cancer therapeutics.

More Related Videos

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...